Related Experiment Video
Updated: Jun 2, 2026

Screening for Amyloid Aggregation by Semi-Denaturing Detergent-Agarose Gel Electrophoresis
Published on: July 16, 2008
A multistage pathway for human prion protein aggregation in vitro: from multimeric seeds to β-oligomers and
Kang R Cho1, Yu Huang, Shuiliang Yu
1Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California 94550, USA.
Abstract:
Aberrant protein aggregation causes numerous neurological diseases including Creutzfeldt-Jakob disease (CJD), but the aggregation mechanisms remain poorly understood. Here, we report AFM results on the formation pathways of β-oligomers and nonfibrillar aggregates from wild-type full-length recombinant human prion protein (WT) and an insertion mutant (10OR) with five additional octapeptide repeats linked to familial CJD. Upon partial denaturing, seeds consisting of 3-4 monomers quickly appeared. Oligomers of ~11-22 monomers then formed through direct interaction of seeds, rather than by subsequent monomer attachment. All larger aggregates formed through association of these β-oligomers. Although both WT and 10OR exhibited identical aggregation mechanisms, the latter oligomerized faster due to lower solubility and, hence, thermodynamic stability. This novel aggregation pathway has implications for prion diseases as well as others caused by protein aggregation.
Insights
Aberrant protein aggregation, a hallmark of Creutzfeldt-Jakob disease (CJD), was studied. Researchers discovered that protein aggregates form through the association of smaller β-oligomers, not by adding single proteins.
Area of Science:
- Biochemistry
- Neuroscience
- Structural Biology
Background:
- Aberrant protein aggregation is implicated in numerous neurodegenerative diseases, including Creutzfeldt-Jakob disease (CJD).
- The precise mechanisms underlying prion protein aggregation remain largely unknown.
- Understanding these pathways is crucial for developing therapeutic strategies.
Purpose of the Study:
- To elucidate the formation pathways of β-oligomers and nonfibrillar aggregates of human prion protein.
- To compare the aggregation mechanisms of wild-type (WT) prion protein with an insertion mutant (10OR) linked to familial CJD.
- To investigate the role of protein solubility and thermodynamic stability in aggregation kinetics.
Main Methods:
- Atomic Force Microscopy (AFM) was employed to visualize and analyze protein aggregate formation.
- Partial denaturation of recombinant full-length human prion protein (WT and 10OR mutant) was performed.
- Kinetic and structural characteristics of aggregation intermediates were assessed.
Main Results:
- Small seeds (3-4 monomers) rapidly formed upon partial denaturation.
- β-oligomers (~11-22 monomers) assembled via direct seed interaction, not sequential monomer addition.
- Larger aggregates formed exclusively through the association of these β-oligomers.
- Both WT and 10OR proteins followed identical aggregation pathways.
- The 10OR mutant exhibited faster oligomerization due to reduced solubility and thermodynamic stability.
Conclusions:
- A novel protein aggregation pathway was identified, involving the self-assembly of β-oligomers.
- This pathway is conserved between wild-type and a familial CJD-associated mutant prion protein.
- Differences in solubility and stability dictate the aggregation rate, offering insights into prion disease pathogenesis.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Folding
Protein Folding

